That's fiddly to calculate for COVID ARDS as waves of COVID infections are difficult to guess. I guess just treat it as growth potential.
As for Non-covid ARDS (the more stable treatment opportunity), assuming pricing is the same as US (which is probably optimistic) royalty revenue for top 5 European countries by population would be about AUD $600M. With less optimistic pricing maybe add AUD $400M royalty revenue.
I've assumed 20% of the moderate and severe cases are treated.
I guess a deal for Europe would most likely be for all of Europe rather than just the top 5 countries.
Depending on P/E used would add $17.55 to $55.28 to the MSB share price.
- Forums
- ASX - By Stock
- MSB
- MSB - Most exciting 6 months
MSB - Most exciting 6 months, page-402
- There are more pages in this discussion • 328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.0¢ |
Change
-0.095(8.76%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
$1.12 | $1.12 | 98.0¢ | $26.84M | 25.91M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25272 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 6571 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25272 | 0.990 |
7 | 62775 | 0.985 |
8 | 261883 | 0.980 |
3 | 53000 | 0.975 |
7 | 129413 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 6571 | 1 |
1.000 | 124360 | 4 |
1.005 | 20000 | 2 |
1.010 | 1742 | 1 |
1.015 | 30591 | 3 |
Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
Last
99.5¢ |
  |
Change
-0.095 ( 7.78 %) |
|||
Open | High | Low | Volume | ||
$1.12 | $1.12 | 98.0¢ | 3288218 | ||
Last updated 15.59pm 30/04/2024 ? |
Featured News
MSB (ASX) Chart |